Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meeting

Despite the availability of various anticancer agents, Multiple Myeloma (MM) remains incurable in most cases, along with high relapse rate in the patients treated with these agents. The year 2015 saw major advancements in our battle against multiple myeloma. In 2015, the U.S. Food and Drug Administr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kejie, Desai, Aakash, Zeng, Dongfeng, Gong, Tiejun, Lu, Peihua, Wang, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354697/
https://www.ncbi.nlm.nih.gov/pubmed/27863374
http://dx.doi.org/10.18632/oncotarget.13314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354697/
https://www.ncbi.nlm.nih.gov/pubmed/27863374
http://dx.doi.org/10.18632/oncotarget.13314

Ejemplares similares